Ata, Elenita .
HRN: 16-72-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/05/2023
11/11/2023
IV
500mg
Q8
T/C Obstructive Jaundice Sec To Choledocholelithiases
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes